Literature DB >> 25003765

PTPN22: the archetypal non-HLA autoimmunity gene.

Stephanie M Stanford1, Nunzio Bottini1.   

Abstract

PTPN22 encodes a tyrosine phosphatase that is expressed by haematopoietic cells and functions as a key regulator of immune homeostasis by inhibiting T-cell receptor signalling and by selectively promoting type I interferon responses after activation of myeloid-cell pattern-recognition receptors. A single nucleotide polymorphism of PTPN22, 1858C>T (rs2476601), disrupts an interaction motif in the protein, and is the most important non-HLA genetic risk factor for rheumatoid arthritis and the second most important for juvenile idiopathic arthritis. PTPN22 exemplifies a shared autoimmunity gene, affecting the pathogenesis of systemic lupus erythematosus, vasculitis and other autoimmune diseases. In this Review, we explore the role of PTPN22 in autoimmune connective tissue disease, with particular emphasis on candidate-gene and genome-wide association studies and clinical variability of disease. We also propose a number of PTPN22-dependent functional models of the pathogenesis of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25003765      PMCID: PMC4375551          DOI: 10.1038/nrrheum.2014.109

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  121 in total

1.  PTPN22 alters the development of regulatory T cells in the thymus.

Authors:  Christian J Maine; Emma E Hamilton-Williams; Jocelyn Cheung; Stephanie M Stanford; Nunzio Bottini; Linda S Wicker; Linda A Sherman
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

2.  Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling.

Authors:  Adrian F Arechiga; Tania Habib; Yantao He; Xian Zhang; Zhong-Yin Zhang; Andrew Funk; Jane H Buckner
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

3.  Testing for linkage and association with rheumatoid arthritis a ptpn22 promoter polymorphism reported to be associated and linked with type 1 diabetes in the Caucasian population.

Authors:  P Dieudé; V H Teixeira; C Pierlot; F Cornélis; E Petit-Teixeira
Journal:  Ann Rheum Dis       Date:  2008-06       Impact factor: 19.103

4.  Genome-wide analysis of histone H3 lysine 4 trimethylation by ChIP-chip in peripheral blood mononuclear cells of systemic lupus erythematosus patients.

Authors:  Y Dai; L Zhang; C Hu; Y Zhang
Journal:  Clin Exp Rheumatol       Date:  2010-05-13       Impact factor: 4.473

5.  The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status.

Authors:  A T Lee; W Li; A Liew; C Bombardier; M Weisman; E M Massarotti; J Kent; F Wolfe; A B Begovich; P K Gregersen
Journal:  Genes Immun       Date:  2005-03       Impact factor: 2.676

6.  A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Authors:  Ann B Begovich; Victoria E H Carlton; Lee A Honigberg; Steven J Schrodi; Anand P Chokkalingam; Heather C Alexander; Kristin G Ardlie; Qiqing Huang; Ashley M Smith; Jill M Spoerke; Marion T Conn; Monica Chang; Sheng-Yung P Chang; Randall K Saiki; Joseph J Catanese; Diane U Leong; Veronica E Garcia; Linda B McAllister; Douglas A Jeffery; Annette T Lee; Franak Batliwalla; Elaine Remmers; Lindsey A Criswell; Michael F Seldin; Daniel L Kastner; Christopher I Amos; John J Sninsky; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

7.  Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.

Authors:  E W Karlson; L B Chibnik; J Cui; R M Plenge; R J Glass; N E Maher; A Parker; R Roubenoff; E Izmailova; J S Coblyn; M E Weinblatt; N A Shadick
Journal:  Ann Rheum Dis       Date:  2007-07-31       Impact factor: 19.103

8.  Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production.

Authors:  Sharon A Chung; Kimberly E Taylor; Robert R Graham; Joanne Nititham; Annette T Lee; Ward A Ortmann; Chaim O Jacob; Marta E Alarcón-Riquelme; Betty P Tsao; John B Harley; Patrick M Gaffney; Kathy L Moser; Michelle Petri; F Yesim Demirci; M Ilyas Kamboh; Susan Manzi; Peter K Gregersen; Carl D Langefeld; Timothy W Behrens; Lindsey A Criswell
Journal:  PLoS Genet       Date:  2011-03-03       Impact factor: 5.917

9.  Overlap of disease susceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis.

Authors:  Anne Hinks; Steve Eyre; Xiayi Ke; Anne Barton; Paul Martin; Edward Flynn; Jon Packham; Jane Worthington; Wendy Thomson
Journal:  Ann Rheum Dis       Date:  2009-08-11       Impact factor: 19.103

10.  Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes.

Authors:  W S Thompson; M L Pekalski; H Z Simons; D J Smyth; X Castro-Dopico; H Guo; C Guy; D B Dunger; S Arif; M Peakman; C Wallace; L S Wicker; J A Todd; R C Ferreira
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

View more
  84 in total

1.  Evaluation of a DLA-79 allele associated with multiple immune-mediated diseases in dogs.

Authors:  Steven G Friedenberg; Greg Buhrman; Lhoucine Chdid; Natasha J Olby; Thierry Olivry; Julien Guillaumin; Theresa O'Toole; Robert Goggs; Lorna J Kennedy; Robert B Rose; Kathryn M Meurs
Journal:  Immunogenetics       Date:  2015-12-28       Impact factor: 2.846

Review 2.  Genetics of autoimmune diseases: perspectives from genome-wide association studies.

Authors:  Yuta Kochi
Journal:  Int Immunol       Date:  2016-02-08       Impact factor: 4.823

Review 3.  Sequential Immune Responses: The Weapons of Immunity.

Authors:  Charles D Mills; Klaus Ley; Kurt Buchmann; Johnathan Canton
Journal:  J Innate Immun       Date:  2015-04-02       Impact factor: 7.349

Review 4.  Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases.

Authors:  Jessica A Hamerman; Jessica Pottle; Minjian Ni; Yantao He; Zhong-Yin Zhang; Jane H Buckner
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

Review 5.  Genetic basis of autoimmunity.

Authors:  Alexander Marson; William J Housley; David A Hafler
Journal:  J Clin Invest       Date:  2015-06-01       Impact factor: 14.808

6.  Identification of susceptibility SNPs in CTLA-4 and PTPN22 for scleritis in Han Chinese.

Authors:  F Li; X Ma; L Du; L Shi; Q Cao; N Li; T Pang; Y Liu; A Kijlstra; P Yang
Journal:  Clin Exp Immunol       Date:  2019-04-16       Impact factor: 4.330

7.  The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.

Authors:  Daniela Josabeth López-Cano; Daniel Cadena-Sandoval; Olga Beltrán-Ramírez; Rosa Elda Barbosa-Cobos; Fausto Sánchez-Muñoz; Luis Manuel Amezcua-Guerra; Yaneli Juárez-Vicuña; María Concepción Aguilera-Cartas; José Moreno; Jesús Bautista-Olvera; Guillermo Valencia-Pacheco; Ricardo F López-Villanueva; Julian Ramírez-Bello
Journal:  Inflamm Res       Date:  2017-05-12       Impact factor: 4.575

8.  DUSP23 is over-expressed and linked to the expression of DNMTs in CD4+ T cells from systemic lupus erythematosus patients.

Authors:  E Balada; L Felip; J Ordi-Ros; M Vilardell-Tarrés
Journal:  Clin Exp Immunol       Date:  2016-11-16       Impact factor: 4.330

9.  The Csk-Associated Adaptor PAG Inhibits Effector T Cell Activation in Cooperation with Phosphatase PTPN22 and Dok Adaptors.

Authors:  Dominique Davidson; Ming-Chao Zhong; Pier Paolo Pandolfi; Silvia Bolland; Ramnik J Xavier; Brian Seed; Xin Li; Hua Gu; André Veillette
Journal:  Cell Rep       Date:  2016-12-06       Impact factor: 9.423

Review 10.  The potential role for infections in the pathogenesis of autoimmune Addison's disease.

Authors:  A Hellesen; E Bratland
Journal:  Clin Exp Immunol       Date:  2018-09-30       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.